Special-medical-purpose formulated food for cancer patient

A technology for formula food and tumor patients, which is applied in the directions of food ingredients, functions of food ingredients, and food ingredients containing vitamins, etc., can solve the problems of lack of full-nutrition formula food and poor effect, etc.

Inactive Publication Date: 2019-08-23
上海利康精准医疗技术有限公司
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, most of the current nutritional formula foods are only suitable for specific types of tumor patients, and the effect on other types of tumor patients is not good;

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] This embodiment is a preferred form of formula food for special medical purposes for tumor patients, which includes the following components:

[0032] Whey protein 10g, soybean protein powder 10g, soybean peptide powder 5g, arginine 0.5g;

[0033] α-linolenic acid 2g, eicosapentaenoic acid 2g, docosapentaenoic acid 2g, docosahexaenoic acid 6g;

[0034] Maltodextrin 35g, starch 5g;

[0035] Fructose-oligosaccharide 5g, inulin 2g;

[0036] Mushroom powder 1.5g, kelp powder 1g, corn flour 2g, chicken powder 2g, broccoli powder 2g;

[0037] Sodium 440mg, Potassium 590mg, Copper 245μg, Magnesium 105mg, Iron 4.5mg, Zinc 4.5mg, Manganese 225μg, Calcium 295mg, Phosphorus 210mg, Iodine 35μg, Selenium 25μg;

[0038] Vitamin A 200μg, Vitamin D 4μg, Vitamin E 4mg, Vitamin K 1 25μg, vitamin B 1 0.7mg, vitamin B 2 0.7mg, vitamin B 6 0.7mg, vitamin B 12 0.7μg, niacin 4mg, folic acid 0.2mg, pantothenic acid 1.5mg, vitamin C 80mg, biotin 12μg;

[0039] Purslane 0.8g, Houtt...

Embodiment 2

[0043] This embodiment is a preferred form of formula food for special medical purposes for tumor patients, which includes the following components:

[0044] Whey protein 10g, fish scale collagen 5g, whole milk powder 8g, soybean protein powder 10g, arginine 0.5g, leucine 0.5g;

[0045] α-linolenic acid 3g, docosahexaenoic acid 9g;

[0046] Maltodextrin 38g, glucose 3g, starch 7g;

[0047]5g fructo-oligosaccharide, 1g pectin, 1g β-glucan;

[0048] Mushroom powder 2g, kelp powder 1g, corn flour 2g, chicken powder 1g, black tea powder 1g, broccoli powder 1g;

[0049] Sodium 450mg, Potassium 585mg, Copper 225μg, Magnesium 98mg, Iron 4.9mg, Zinc 4.8mg, Manganese 240μg, Calcium 315mg, Phosphorus 205mg, Iodine 39μg, Selenium 27.5μg;

[0050] Vitamin A 220μg, Vitamin D 4.8μg, Vitamin E 4.5mg, Vitamin K 1 22μg, Vitamin B 1 0.75mg, vitamin B 2 0.75mg, vitamin B 6 0.75mg, vitamin B 12 0.75μg, niacin 3.8mg, folic acid 0.21mg, pantothenic acid 1.7mg, vitamin C 82mg, biotin 12....

Embodiment 3

[0055] This embodiment is a preferred form of formula food for special medical purposes for tumor patients, which includes the following components:

[0056] 20-40 servings of protein, 10-15 servings of fat, 25-55 servings of carbohydrates, 4-10 servings of dietary fiber, 2-10 servings of dietary essence, 0.01-2 servings of mineral complexes; 0.01-1 servings of vitamin complexes; 1 to 5 servings of medicinal and edible ingredients

[0057] Fish scale collagen 5g, whole milk powder 15g, soybean peptide powder 15g, nucleotide 0.2g, arginine 0.4g, leucine 0.4g;

[0058] Docosahexaenoic acid 10g;

[0059] Maltodextrin 27g, starch 13g;

[0060] 6g fructo-oligosaccharide, 3g xylo-oligosaccharide;

[0061] Mushroom powder 0.5g, kelp powder 0.5g, konjac powder 0.5g, walnut powder 0.5g, black tea powder 0.5g, apple powder 0.5g, corn powder 0.5g, chicken powder 0.5g, broccoli powder 0.5g;

[0062] Sodium 435mg, Potassium 602mg, Copper 243μg, Magnesium 105mg, Iron 4.3mg, Zinc 4.3mg, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a special-medical-purpose formulated food for a cancer patient. The special-medical-purpose formulated food is prepared from 20-40 parts of protein, 10-15 parts of fat, 25-55 parts of a carbohydrate, 4-10 parts of dietary fibers, 2-10 parts of dietary essence, 0.01-2 parts of a mineral substance, 0.01-1 part of a vitamin compound and 1-5 parts of medicine-food-homology components, wherein the fat is omega-3 polyunsaturated fatty acid, and the omega-3 polyunsaturated fatty acid comprises at least one of alpha-linolenic acid, timnodonic acid, docosapentaenoic acid and docosahexaenoic acid; the dietary essence comprises at least one of mushroom powder, kelp powder, konjac flour, walnut powder, black tea powder, apple powder, corn flour, chicken meal and broccoli powder. The food has important effects of maintaining and guaranteeing physiological functions and physical rehabilitation of people in the state of suffering from tumor diseases, can significantly alleviate weight loss of the cancer patient, reduce complications, increase the nutrition intake of the cancer patient and improve living quality, becomes fourth therapy with the same importance as operations, radiotherapy and chemotherapy, and is used for whole-process therapy of the cancer patient.

Description

technical field [0001] The invention relates to a food formula, in particular to a special medical formula food for tumor patients. Background technique [0002] Malnutrition in cancer patients not only leads to decreased tolerance to treatment, decreased therapeutic effect, decreased quality of life, shortened survival time, and increased complications, but also brings a huge economic burden to the patient's family. [0003] Tumor diseases often cause metabolic disorders and physical deterioration of patients, and can cause malnutrition to varying degrees. Although surgery is a treatment for tumors, it is also a trauma to the body. Due to the stimulation of surgery and the need for wound tissue repair, the body's catabolism is enhanced, and the demand for nutrients such as protein increases. At the same time, the resistance of postoperative patients is reduced, and postoperative patients often have symptoms such as fever, infection, metabolic disorders, loss of appetite, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A23L33/00A23L33/19A23L33/185A23L33/18A23L33/175A23L33/13A23L33/17A23L33/12A23L33/21A23L33/22A23L33/125A23L33/15A23L33/155A23L33/16A23L33/10
CPCA23L33/40A23L33/19A23L33/185A23L33/18A23L33/175A23L33/13A23L33/17A23L33/12A23L33/21A23L33/22A23L33/125A23L33/15A23L33/155A23L33/16A23L33/10A23V2002/00A23V2200/308A23V2200/30A23V2250/54252A23V2250/5422A23V2250/5488A23V2250/55A23V2250/0628A23V2250/0606A23V2250/186A23V2250/702A23V2250/71A23V2250/712A23V2250/7142A23V2250/7042A23V2250/7044A23V2250/7052A23V2250/706A23V2250/7056A23V2250/7046A23V2250/705A23V2250/708A23V2250/1614A23V2250/16A23V2250/1588A23V2250/1592A23V2250/1612A23V2250/1578A23V2250/1618A23V2250/1598A23V2250/1626
Inventor 毛丹丹傅咏南王校卞雪莲
Owner 上海利康精准医疗技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap